Bactrim Dosage for MRSA Wound Infection

Adult Dosing Recommendations

The Infectious Diseases Society of America (IDSA) recommends using trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets (160/800 mg) twice daily for 7-14 days for MRSA wound infections in adults with normal renal function, with the higher dose (2 DS tablets = 320/1600 mg twice daily) preferred for more extensive or severe infections 1, 2
The standard dosing for purulent cellulitis or uncomplicated MRSA wound infections is 1-2 double-strength (DS) tablets orally twice daily, with each DS tablet containing 160 mg trimethoprim and 800 mg sulfamethoxazole 1, 2

The treatment duration for MRSA wound infections is 7-14 days depending on infection severity and clinical response, with simple infections requiring only 5-10 days and more complicated infections warranting the full 14-day course 1, 3, 4

For children, the dose is based on the trimethoprim component, with a recommended dose of trimethoprim 4-6 mg/kg/dose, sulfamethoxazole 20-30 mg/kg/dose orally every 12 hours 1, 2
TMP-SMX is contraindicated in children under 2 months of age 1, 2

The IDSA guidelines provide Level AII evidence supporting TMP-SMX for MRSA skin and soft tissue infections, with a cure rate of 91.9% for uncomplicated wound infections 1, 2

TMP-SMX has poor activity against beta-hemolytic streptococci, and if streptococcal coverage is needed, it should be combined with a beta-lactam (amoxicillin or cephalexin) or clindamycin instead 1, 3
For simple abscesses, incision and drainage alone may be adequate without antibiotics, but antibiotics should be added if there are signs of severe or extensive disease, systemic illness, or comorbidities/immunosuppression 1, 4

TMP-SMX is pregnancy category C/D and is not recommended in the third trimester, and is contraindicated in sulfa allergy 1, 2, 5

Alternative agents for MRSA wound infections include clindamycin 300-450 mg orally three times daily, doxycycline 100 mg orally twice daily, and linezolid 600 mg orally twice daily 1, 2, 3, 4

For MRSA‑associated skin and soft‑tissue infections, doxycycline 100 mg orally twice daily is an evidence‑based alternative to Bactrim, and it can be safely prescribed to children older than 8 years for courses shorter than 2 weeks. (Pediatrics guideline) 6

Doxycycline should not be used in patients younger than 8 years because of the risk of permanent tooth discoloration. (Pediatrics guideline) 6

Current dermatology guidelines report no clinically significant pharmacokinetic or pharmacodynamic interaction between Bactrim and doxycycline; the only noted interaction involving tetracyclines is with methotrexate, which does not apply to this combination. (British Association of Dermatologists guidance) 7

Acne treatment guidelines from the American Academy of Dermatology list Bactrim and doxycycline as interchangeable options and do not contraindicate their concurrent use. (American Academy of Dermatology guideline) 8
The same American Academy of Dermatology guidance reiterates that the two agents may be used together when clinically appropriate, without specific warnings against combination therapy. (American Academy of Dermatology guideline) 9